ATCC® VR-1992™ | Severe acute respiratory syndrome coronavirus 2

Overview

Related Genomes

Quality Control

Organism Summary
Name	ATCC® VR-1992™
Isolation	Derived from 2019-nCoV/Italy-INMI1, which was originally isolated from sputum of a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Rome, Italy. This item has 4 sequence variants (3 with single nucleotide polymorphisms and one 30 nucleotide deletion in the Spike CDS region) compared to the original clinical isolate sequence.
Biosafety Level	3
Type Strain	No

Input Reads Summary
Oxford Nanopore Read Count	0
Illumina Read Count	2,499,346
Illumina Mean Coverage Depth	1,739.884×
Illumina Median Q Score	38

Sequencing Quality Control

Quality control statistics on Illumina sequencing data.

4 out of 4 passed

PassedNumber of trimmed reads2,499,346

PassedMedian Q score, all bases38

PassedPercent of median Q scores per cycle greater than 25100%

PassedAmbiguous content (% N bases)0%

Metrics assessing the assembly quality (from CheckM).

3 out of 3 passed

PassedEstimated genome completeness100%

PassedEstimated genome contamination0%

PassedAverage depth of coverage1,739.884×